Get the Stockscreener App
1.87
8.33%
-0.17
After Hours:
1.89
0.02
+1.07%
Palisade Bio Inc stock is traded at $1.87, with a volume of 2.02M.
It is down -8.33% in the last 24 hours and up +1.08% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$2.04
Open:
$2
24h Volume:
2.02M
Relative Volume:
0.29
Market Cap:
$17.05M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.1337
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
+12.65%
1M Performance:
+1.08%
6M Performance:
+156.13%
1Y Performance:
-15.00%
1-Day Range:
$1.83
$2.02
1-Week Range:
$1.515
$2.07
52-Week Range:
$0.53
$3.30
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.87 | 304.30M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Palisade Bio Inc Stock (PALI) Latest News
Using RSI to spot recovery in Palisade Bio Inc.Insider Buying & Comprehensive Market Scan Insights - newser.com
Why Palisade Bio Inc. (7NS0) stock is upgraded to buyJuly 2025 Movers & Verified Chart Pattern Trade Signals - newser.com
What MACD and RSI say about Palisade Bio Inc.Gap Down & Precise Buy Zone Tips - newser.com
Why Palisade Bio Inc. stock could be next big winner2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Why Palisade Bio Inc. stock remains resilientJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
Forecasting Palisade Bio Inc. price range with options dataMarket Trend Report & Stock Portfolio Risk Control - newser.com
Will Palisade Bio Inc. stock deliver better than expected guidanceJuly 2025 Setups & Expert Curated Trade Setups - newser.com
Published on: 2025-11-11 06:56:37 - newser.com
Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher - sharewise.com
How to track smart money flows in Palisade Bio Inc.Earnings Recap Report & Fast Entry Momentum Alerts - newser.com
Palisade Bio Inc. recovery potential after sell off2025 Trading Volume Trends & Reliable Price Action Trade Plans - newser.com
Is Palisade Bio Inc. stock attractive for retirement portfoliosMarket Volume Summary & Smart Investment Allocation Insights - newser.com
Should I hold or sell Palisade Bio Inc. stock in 2025Weekly Profit Summary & Daily Chart Pattern Signals - newser.com
Palisade Bio Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
[Form 4/A] PALISADE BIO, INC. Amended Insider Trading Activity - Stock Titan
All You Need to Know About Palisade Bio (PALI) Rating Upgrade to Buy - Yahoo Finance
Can volume confirm reversal in Palisade Bio Inc.2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
Is Palisade Bio Inc. stock cheap at current valuationTrade Exit Report & Verified Swing Trading Watchlist - fcp.pa.gov.br
Palisade Bio Inc. stock momentum explainedEarnings Overview Report & Expert Verified Movement Alerts - newser.com
Using data filters to optimize entry into Palisade Bio Inc.Weekly Stock Report & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-06 00:01:19 - newser.com
Bearish Setup: Why Palisade Bio Inc. stock is considered a top pick2025 Institutional Moves & Consistent Growth Equity Picks - Fundação Cultural do Pará
Will Palisade Bio Inc. stock benefit from AI adoptionQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Palisade Bio Inc Stock (PALI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wei Binxian | Director |
Nov 21 '24 |
Option Exercise |
0.00 |
388 |
0 |
855 |
0.35%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):